Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2024 Earnings
MRVI·Reported May 8, 2024·After market close
Maravai LifeSciences Holdings, Inc. reported Q1 2024 revenue of $64.2M, beat analyst consensus of $60.6M by $3.6M. Diluted EPS came in at $-0.02, missed the $-0.02 consensus by $0.00.
Revenue
$64.2Mbeat by $3.6M
Consensus: $60.6MDiluted EPS
$-0.02missed by $0.00
Consensus: $-0.02
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Maravai LifeSciences Holdings, Inc.'s Q1 2024 earnings report.
Maravai LifeSciences Holdings, Inc. (MRVI) reported Q1 2024 earnings on May 8, 2024 after market close.
Maravai LifeSciences Holdings, Inc. reported revenue of $64.2M and diluted EPS of $-0.02 for Q1 2024.
Revenue beat the consensus estimate of $60.6M by $3.6M. EPS missed the consensus estimate of $-0.02 by $0.00.
You can read the 10-Q periodic report (0001823239-24-000060) directly on SEC EDGAR. The filing index links above go to sec.gov.